The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Weymann, Andreas
    Consultant born in January 1968
    Individual (2 offsprings)
    Officer
    2020-06-01 ~ now
    OF - Director → CIF 0
  • 2
    Freemont, Anthony John
    Medical Professor born in March 1953
    Individual (2 offsprings)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 3
    Cannon, Bradley Jay
    Business Executive born in January 1968
    Individual (1 offspring)
    Officer
    2022-11-04 ~ now
    OF - Director → CIF 0
  • 4
    Bakri, Rached Sami, Dr
    Entrepreneur born in July 1977
    Individual (3 offsprings)
    Officer
    2016-10-19 ~ now
    OF - Director → CIF 0
  • 5
    Fiore, Michael
    Health Care Executive/Consultant born in April 1954
    Individual (1 offspring)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
Ceased 11
  • 1
    Khattar, Navin
    Executive Director born in December 1972
    Individual (20 offsprings)
    Officer
    2018-05-24 ~ 2022-11-04
    OF - Director → CIF 0
  • 2
    Freemont, Anthony John
    University Professor born in March 1953
    Individual (2 offsprings)
    Officer
    2012-07-17 ~ 2016-10-19
    OF - Director → CIF 0
  • 3
    Thorpe, Jayne
    Individual (7 offsprings)
    Officer
    2017-03-07 ~ 2021-02-28
    OF - Secretary → CIF 0
  • 4
    Goldsmith, David Julian Alexander, Professor
    Medical Practitioner born in August 1959
    Individual (2 offsprings)
    Officer
    2016-10-19 ~ 2018-03-22
    OF - Director → CIF 0
  • 5
    Von Celsing, Hans Henrik
    Business Director born in July 1950
    Individual (1 offspring)
    Officer
    2012-11-14 ~ 2018-03-22
    OF - Director → CIF 0
  • 6
    Speers, Paula Ness
    Business Executive born in November 1957
    Individual
    Officer
    2022-11-04 ~ 2024-09-17
    OF - Director → CIF 0
  • 7
    Saunders, Brian Roy
    Reader In Polymer Chemistry born in March 1964
    Individual
    Officer
    2012-07-17 ~ 2015-03-23
    OF - Director → CIF 0
  • 8
    Jenny, Philippe, Dr
    Consultant born in July 1955
    Individual
    Officer
    2012-11-14 ~ 2022-11-29
    OF - Director → CIF 0
  • 9
    De Geer, Gustaf Hugo Gerard
    Chairman Of The Board Brialmont Ab born in July 1949
    Individual
    Officer
    2016-10-19 ~ 2022-11-04
    OF - Director → CIF 0
  • 10
    NWF4B DIRECTORS LIMITED
    131, Mount Pleasant, Liverpool
    Dissolved Corporate (2 parents, 4 offsprings)
    Equity (Company account)
    1 GBP2021-12-31
    Officer
    2014-03-07 ~ 2016-09-30
    PE - Director → CIF 0
  • 11
    QUESTER VENTURE MANAGERS LIMITED - 2010-04-22
    PARQUEST CAPITAL MANAGEMENT LIMITED - 2001-01-12
    AMPLEPINE LIMITED - 1989-02-27
    131, Liverpool Science Park, 131 Mount Pleasant, Liverpool, England
    Active Corporate (2 parents, 4 offsprings)
    Profit/Loss (Company account)
    41,321 GBP2023-01-01 ~ 2023-12-31
    Person with significant control
    2016-06-01 ~ 2016-10-19
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firm → CIF 0
parent relation
Company in focus

GELMETIX LIMITED

Previous name
GELEXIR HEALTHCARE LIMITED - 2018-08-20
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
82023-01-01 ~ 2023-12-31
82022-01-01 ~ 2022-12-31
Intangible Assets
455,687 GBP2023-12-31
455,687 GBP2022-12-31
Property, Plant & Equipment
26,477 GBP2022-12-31
Fixed Assets
455,687 GBP2023-12-31
482,164 GBP2022-12-31
Debtors
Current
285,467 GBP2023-12-31
228,854 GBP2022-12-31
Cash at bank and in hand
432,689 GBP2023-12-31
1,925,021 GBP2022-12-31
Current Assets
718,156 GBP2023-12-31
2,153,875 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-311,204 GBP2023-12-31
-512,060 GBP2022-12-31
Net Current Assets/Liabilities
406,952 GBP2023-12-31
1,641,815 GBP2022-12-31
Total Assets Less Current Liabilities
862,639 GBP2023-12-31
2,123,979 GBP2022-12-31
Creditors
Non-current, Amounts falling due after one year
-800,916 GBP2023-12-31
-272,206 GBP2022-12-31
Net Assets/Liabilities
61,723 GBP2023-12-31
1,851,773 GBP2022-12-31
Equity
Called up share capital
264,306 GBP2023-12-31
264,306 GBP2022-12-31
Share premium
11,592,098 GBP2023-12-31
11,592,098 GBP2022-12-31
Retained earnings (accumulated losses)
-11,794,681 GBP2023-12-31
-10,004,631 GBP2022-12-31
Equity
61,723 GBP2023-12-31
1,851,773 GBP2022-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
252023-01-01 ~ 2023-12-31
Computers
332023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Development expenditure
455,687 GBP2023-12-31
455,687 GBP2022-12-31
Intangible Assets
Development expenditure
455,687 GBP2023-12-31
455,687 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
121,776 GBP2022-12-31
Computers
7,904 GBP2023-12-31
7,904 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
7,904 GBP2023-12-31
129,680 GBP2022-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-121,776 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals
-121,776 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
96,755 GBP2022-12-31
Computers
6,448 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
103,203 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
2,607 GBP2023-01-01 ~ 2023-12-31
Computers, Owned/Freehold
1,456 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
4,063 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-99,362 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-99,362 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
7,904 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
7,904 GBP2023-12-31
Property, Plant & Equipment
Plant and equipment
25,021 GBP2022-12-31
Computers
1,456 GBP2022-12-31
Other Debtors
Current
266,755 GBP2023-12-31
228,854 GBP2022-12-31
Prepayments/Accrued Income
Current
18,712 GBP2023-12-31
Bank Overdrafts
Current
241 GBP2023-12-31
109 GBP2022-12-31
Bank Borrowings
Current
65,000 GBP2023-12-31
Trade Creditors/Trade Payables
Current
160,212 GBP2023-12-31
419,022 GBP2022-12-31
Taxation/Social Security Payable
Current
3,474 GBP2023-12-31
13,862 GBP2022-12-31
Other Creditors
Current
74,769 GBP2023-12-31
64,567 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
7,508 GBP2023-12-31
14,500 GBP2022-12-31
Creditors
Current
311,204 GBP2023-12-31
512,060 GBP2022-12-31
Bank Borrowings
Non-current
154,888 GBP2023-12-31
272,206 GBP2022-12-31
Trade Creditors/Trade Payables
Non-current
646,028 GBP2023-12-31
Creditors
Non-current
800,916 GBP2023-12-31
272,206 GBP2022-12-31
Bank Borrowings
Current, Amounts falling due within one year
65,000 GBP2023-12-31
Total Borrowings
Current, Amounts falling due within one year
65,000 GBP2023-12-31
Bank Borrowings
Non-current, Between one and two years
154,888 GBP2023-12-31
272,206 GBP2022-12-31
Total Borrowings
219,888 GBP2023-12-31
272,206 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
264,306 shares2023-12-31
264,306 shares2022-12-31
Par Value of Share
Class 1 ordinary share
1.002023-01-01 ~ 2023-12-31
  • GELMETIX LIMITED
    Info
    GELEXIR HEALTHCARE LIMITED - 2018-08-20
    Registered number 08146622
    Askwith Business Services Parkside House, 17 East Parade, Harrogate HG1 5LF
    Private Limited Company incorporated on 2012-07-17 (12 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.